SCHEMBL24528637

SCHEMBL24528637

O=Cc1ccc(-c2nc(-c3ccc(C=O)cc3)c3sccc3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MTOR P42345 7/20 0.39
PIK3CA P42336 6/20 0.39
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
PTGS1 P23219 1/20 0.37
CYP2A6 P11509 1/20 0.36
ADORA2A P29274 5/20 0.35
ADORA1 P30542 5/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29681010 1.00 MTOR (0.39) MTORPIK3CAPDE4APDE4BPDE4C
SCHEMBL24528608 0.84 ADORA2A (0.52) PTGS1CYP2A6ADORA2AADORA1RAB9A
SCHEMBL29681048 0.84 ADORA2A (0.52) PTGS1CYP2A6ADORA2AADORA1RAB9A
SCHEMBL29681221 0.77 ADORA2A (0.45) PIK3CAPDE4BPTGS1CYP2A6ADORA2A
SCHEMBL24528629 0.77 ADORA2A (0.45) PIK3CAPDE4BPTGS1CYP2A6ADORA2A
SCHEMBL19106707 0.75 PDE4A (0.49) MTORPIK3CAPDE4APDE4BPDE4C
SCHEMBL19106706 0.75 PDE4A (0.49) MTORPIK3CAPDE4APDE4BPDE4C
SCHEMBL23637787 0.72 ALDH1A1 (0.46) CYP2A6SMN1; SMN2MAPT
SCHEMBL24528628 0.72 ADORA2A (0.34) MTORPIK3CAPDE4APDE4BPDE4C
SCHEMBL30488661 0.70 DRD1 (0.45) CYP2A6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022129376-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2022-06-23 WO disclosed